オンコセラピー・サイエンス(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4564/E05363 | OncoTherapy Science,Inc. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2013/10/18 | 日証協 | 3,320,046株 | -3.98% | 728,871株 | -72.76% | 2,206,993株 | +6.46% | 612,800株 | -24.35% |
| 2013/10/11 | 日証協 | 3,457,755株 | -25.75% | 2,675,791株 | -20.01% | 2,073,002株 | -16.74% | 810,094株 | -62.69% |
| 2013/10/04 | 日証協 | 4,656,990株 | +9999.99% | 3,345,092株 | +169.79% | 2,489,937株 | +1436.96% | 2,171,074株 | +488.24% |
| 2013/09/27 | 日証協 | 6,487株 | +18.12% | 1,239,896株 | +9999.99% | 162,004株 | +1270.82% | 369,077株 | +9999.99% |
| 2013/09/20 | 日証協 | 5,492株 | -33.63% | 203株 | -88.6% | 11,818株 | -13.7% | 142株 | -77.6% |
| 2013/09/13 | 日証協 | 8,275株 | -38.59% | 1,781株 | -81.12% | 13,694株 | -11.21% | 634株 | -65.58% |
| 2013/09/06 | 日証協 | 13,475株 | -16.25% | 9,434株 | +30.41% | 15,423株 | +77.26% | 1,842株 | -83.61% |
| 2013/08/30 | 日証協 | 16,090株 | +30.58% | 7,234株 | -25.88% | 8,701株 | +31.95% | 11,240株 | +224.95% |
| 2013/08/23 | 日証協 | 12,322株 | +84.41% | 9,760株 | +1087.35% | 6,594株 | +36.75% | 3,459株 | -1.09% |
| 2013/08/16 | 日証協 | 6,682株 | -6.01% | 822株 | +49.73% | 4,822株 | +9.59% | 3,497株 | +505.02% |
| 2013/08/09 | 日証協 | 7,109株 | -1.32% | 549株 | -6.31% | 4,400株 | +0.25% | 578株 | +70% |
| 2013/08/02 | 日証協 | 7,204株 | +5.32% | 586株 | +6.55% | 4,389株 | +5.86% | 340株 | -7.1% |
| 2013/07/26 | 日証協 | 6,840株 | -5.38% | 550株 | +11.79% | 4,146株 | -8.76% | 366株 | +44.66% |
| 2013/07/19 | 日証協 | 7,229株 | -1.01% | 492株 | +21.78% | 4,544株 | -0.74% | 253株 | +61.15% |
| 2013/07/12 | 日証協 | 7,303株 | +23.74% | 404株 | -79.85% | 4,578株 | +17.47% | 157株 | -87.35% |
| 2013/07/05 | 日証協 | 5,902株 | -23.21% | 2,005株 | +119.61% | 3,897株 | -18.32% | 1,241株 | +250.56% |
| 2013/06/28 | 日証協 | 7,686株 | +1.13% | 913株 | +196.43% | 4,771株 | +1.84% | 354株 | -29.34% |
| 2013/06/21 | 日証協 | 7,600株 | +0.54% | 308株 | -62.44% | 4,685株 | +6.99% | 501株 | +2.04% |
| 2013/06/14 | 日証協 | 7,559株 | +3.28% | 820株 | -50.36% | 4,379株 | +5.21% | 491株 | -38.62% |
※株式分割は考慮していませんのでご注意ください。
Page Top